Table 3.

Annual and cumulative productivity losses by strategy relative to 2005 levels in risk factors, screening rates, and adjuvant chemotherapy use

Annual Productivity Losses		2010 ($, billions)			2020 ($, billions)
		Morbidity	Mortality	Total	Morbidity	Mortality	Total
Stabilization and continuation of 2005 levels in risk factors, screening, and chemotherapy	Women	0.28	8.57	8.85	0.37	8.92	9.30
	Men	0.44	11.64	12.08	0.58	11.90	12.48
	Total	0.71	20.21	20.92	0.96	20.83	21.78
STRATEGY
Simultaneous interventions*	Women	0.28	7.95	8.22	0.34	7.17	7.52
	Men	0.44	10.90	11.33	0.53	9.52	10.05
	Total	0.71	18.85	19.56	0.87	16.69	17.57
Risk factors improve	Women	0.28	8.44	8.72	0.35	8.22	8.57
	Men	0.43	11.48	11.91	0.53	10.62	11.15
	Total	0.71	19.92	20.63	0.88	18.83	19.72
Screening rates increase	Women	0.28	8.31	8.59	0.37	8.08	8.45
	Men	0.44	11.30	11.73	0.57	11.06	11.63
	Total	0.72	19.60	20.32	0.94	19.14	20.08
Chemotherapy use increases	Women	0.28	8.33	8.61	0.38	8.64	9.02
	Men	0.44	11.32	11.76	0.59	11.51	12.10
	Total	0.72	19.66	20.37	0.97	20.15	21.12

Cumulative Productivity Losses		2005 through 2010 ($, billions)			2005 through 2020 ($,billions)
		Morbidity	Morbidity	Total	Morbidity	Morbidity	Total
Stabilization and continuation of 2005 levels in risk factors, screening, and chemotherapy	Women	1.54	52.18	53.71	4.85	139.67	144.53
	Men	2.40	70.15	72.55	7.58	187.12	194.70
	Total	3.94	122.33	126.26	12.43	326.79	339.22
STRATEGY
Simultaneous interventions*	Women	1.54	50.07	51.61	4.72	124.85	129.57
	Men	2.41	67.62	70.04	7.35	168.42	175.77
	Total	3.95	117.69	121.65	12.06	293.28	305.34
Risk factors improve	Women	1.53	51.82	53.35	4.72	134.95	139.67
	Men	2.39	69.79	72.18	7.33	179.82	187.15
	Total	3.92	121.61	125.53	12.05	314.77	326.82
Screening rates increase	Women	1.54	51.48	53.02	4.82	132.80	137.62
	Men	2.41	69.20	71.61	7.53	179.37	186.90
	Total	3.96	120.68	124.64	12.35	312.17	324.52
Chemotherapy use increases	Women	1.54	51.15	52.70	4.89	135.98	140.87
	Men	2.41	68.84	71.24	7.63	182.32	189.95
	Total	3.95	119.99	123.94	12.52	318.30	330.82

^*The simulation of the benefits from the implementation of simultaneous interventions allows for a synergistic effect among strategies that results in a different number of deaths than would be achieved with each strategy implemented individually.